Skip to main content

Rovida Advisors Inc.

SEC CIK
0001653857
Latest filing
Feb 10, 2026

The latest 13F from Rovida Advisors Inc. covers Q4 2025 (filed Feb 10, 2026) and reports no long positions. Livermore has 22 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q4 2025

Share counts compared with Q3 2025: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
0
Added
0
Reduced
0
Sold out
12
Est. −$116.0M

Top 5 holdings

Share of this quarter's portfolio value

This filing reports no long positions.

Biggest buys

New and added positions, by estimated amount bought

None this quarter.

Largest weight increases

New and added positions, by percentage points of the portfolio gained

None this quarter.

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. PARPar Technology Corp
    −$29.7MSold outHistory
  2. GOOGLAlphabet Inc.
    −$19.4MSold outHistory
  3. iShares Russell 2000 ETF464287655
    −$12.2MSold out
  4. ALITAlight, Inc. / Delaware
    −$12.1MSold outHistory
  5. UNHUnitedHealth Group Inc
    −$10.4MSold outHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. PARPar Technology Corp
    −25.59 pp25.6% → 0.0%History
  2. GOOGLAlphabet Inc.
    −16.77 pp16.8% → 0.0%History
  3. iShares Russell 2000 ETF464287655
    −10.49 pp10.5% → 0.0%
  4. ALITAlight, Inc. / Delaware
    −10.40 pp10.4% → 0.0%History
  5. UNHUnitedHealth Group Inc
    −8.93 pp8.9% → 0.0%History

Metrics

13F metrics for Q4 2025, computed only from the numbers in the filings. Definitions below.

Portfolio value
$0
−$116.0M (−100.0%) vs. prior quarter
Positions
0
−12 vs. prior quarter
Top 10 concentration
–
Top 10 as share of value
Turnover
0.0%
Q4 2025, one quarter
Average holding period
–
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

20 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $2.36B (Q3 2021)

Q1 2021: $2.13BQ2 2021: $2.31BQ3 2021: $2.36BQ4 2021: $2.23BQ1 2022: $465.6MQ2 2022: $388.6MQ3 2022: $214.7MQ4 2022: $271.8MQ1 2023: $256.4MQ2 2023: $229.4MQ3 2023: $263.1MQ4 2023: $245.2MQ1 2024: $287.6MQ2 2024: $280.4MQ3 2024: $317.7MQ4 2024: $128.5MQ1 2025: $133.5MQ2 2025: $112.4MQ3 2025: $116.0M
Q1 2021Q4 2025
13F filings of Rovida Advisors Inc. by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q4 2025Feb 10, 20260$0–vs. Q3 2025SEC
Q3 2025Nov 12, 202512$116.0MPARGOOGLiShares Russell 2000 ETFvs. Q2 2025SEC
Q2 2025Aug 12, 2025Amended12$112.4MPARALITGOOGLvs. Q1 2025SEC
Q1 2025May 12, 202512$133.5MMSFTGOOGLPARvs. Q4 2024SEC
Q4 2024Feb 12, 202512$128.5MGOOGLALITPARvs. Q3 2024SEC
Q3 2024Nov 12, 202423$317.7MNTBKTOSPARvs. Q2 2024SEC
Q2 2024Aug 13, 202423$280.4MNTBKTOSPARvs. Q1 2024SEC
Q1 2024May 10, 202426$287.6MNTBPARKTOSvs. Q4 2023SEC
Q4 2023Feb 12, 202417$245.2MNTBPARKTOSvs. Q3 2023SEC
Q3 2023Nov 13, 202318$263.1MNTBPARNEEvs. Q2 2023SEC
Q2 2023Aug 11, 202318$229.4MNTBPARKTOSvs. Q1 2023SEC
Q1 2023May 11, 202322$256.4MNTBPARDada Nexus Ltdvs. Q4 2022SEC
Q4 2022Feb 10, 202325$271.8MNTBDada Nexus LtdPARvs. Q3 2022SEC
Q3 2022Nov 10, 202220$214.7MNTBPARDada Nexus Ltdvs. Q2 2022SEC
Q2 2022Aug 12, 202225$388.6MSPYNTBPARvs. Q1 2022SEC
Q1 2022May 10, 202228$465.6MSPYNTBPARvs. Q4 2021SEC
Q4 2021Feb 14, 2022Amended48$2.23BAMZNGOOGLSEvs. Q3 2021SEC
Q3 2021Nov 12, 202152$2.36BSEAMZNGOOGLvs. Q2 2021SEC
Q2 2021Aug 10, 202147$2.31BDada Nexus LtdSEAMZNvs. Q1 2021SEC
Q1 2021May 14, 202149$2.13BDada Nexus LtdAMZNSE–SEC

13D and 13G filings

Companies where Rovida Advisors Inc. reports owning 5% or more on Schedule 13D or 13G, and its latest filings.

Current stakes of 5% or more

Rovida Advisors Inc. does not currently report owning 5% or more of any company.

Latest filings

1 filing on file made by Rovida Advisors Inc. or listing it as a reporting person, newest first.

Schedule 13D and 13G filings by Rovida Advisors Inc.
CompanyFiled (ET)FormStakeChangeEvent dateFiling
BBIGVinco Ventures, Inc.Feb 10, 202113G/AOld format–––SEC